首页> 外国专利> DIAGNOSTIC TECHNIQUE FOR METABOLIC COMPENSATION DISTURBANCES AND METHOD FOR PREDICTION OF RISK OF DEVELOPING IN PATIENTS WIT TYPE 2 DIABETES MELLITUS BY LYMPHOCYTE APOPTOSIS ASSESSMENT

DIAGNOSTIC TECHNIQUE FOR METABOLIC COMPENSATION DISTURBANCES AND METHOD FOR PREDICTION OF RISK OF DEVELOPING IN PATIENTS WIT TYPE 2 DIABETES MELLITUS BY LYMPHOCYTE APOPTOSIS ASSESSMENT

机译:淋巴细胞凋亡评估代谢补偿障碍的诊断技术和预测2型糖尿病患者病情发展的方法

摘要

FIELD: medicine.;SUBSTANCE: for the purpose of diagnosing metabolic compensation disturbances and predicting a risk of developing complications in the patients suffering type 2 diabetes mellitus (type 2 DM), peripheral venous blood is examined for a percentage of apoptotic lymphocytes An+/Pl-. The lymphocyte An+/Pl- value below 3.5 % enables diagnosing a condition of carbohydrate metabolism compensation and predicting a favourable clinical course of the disease for the following year. The lymphocyte An/PI- content within the range 3.5 to 6% provides diagnosing a condition of subcompensation and a moderate risk of developing complications. The An+/Pl- value exceeding 6 % described a condition of decompensation and a high risk of developing chronic complications of type 2 diabetes mellitus.;EFFECT: higher accuracy of prediction and reduction of the risk of developing complications in diabetic patients.;4 ex
机译:领域:医学;物质:为了诊断2型糖尿病(2 DM型)患者的代谢补偿紊乱并预测发生并发症的风险,检查外周静脉血中凋亡淋巴细胞An + / Pl的百分比-低于3.5%的淋巴细胞An + / Pl-值可以诊断碳水化合物代谢补偿的状况,并预测下一年疾病的良好临床进程。淋巴细胞An / PI-含量在3.5%到6%的范围内,可诊断出补偿不足的情况和中等程度的发生并发症的风险。超过6%的An + / Pl-值描述了失代偿的状况和发生2型糖尿病慢性并发症的高风险;效果:更高的预测准确度并降低了糖尿病患者发生并发症的风险; 4

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号